<DOC>
	<DOCNO>NCT01329419</DOCNO>
	<brief_summary>An open label , multi-centre , non-interventional post-marketing surveillance monitor safety and/or efficacy adefovir dipivoxil administer Korean CHB patient accord prescribe information</brief_summary>
	<brief_title>HEPSERA Post Marketing Surveillance</brief_title>
	<detailed_description>This study post-marketing surveillance monitor safety efficacy adefovir dipivoxil identify SAEs , adverse drug reaction ( ADRs ) , unexpected AEs describe precaution warning identify possible factor effect AEs ass effectiveness adefovir dipivoxil real clinical practice marketing . The subject patient prescribed adefovir dipivoxil investigator site base prescription information normal clinical practice .</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<criteria>Patients administrate adefovir dipivoxil site Patients administrate adefovir dipivoxil center initiate date</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>